Elanco Animal Health
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +2,262.1% | +11.5% | +180.4% | -54.0% | -118.3% | – | -6.4% | -40.0% | +99.6% | +3.5% | |
| – | +7.4% | +25.2% | -7.0% | +6.3% | +64.4% | +38.5% | -4.7% | +1.8% | -4.6% | +2.7% | |
| – | +52.2% | +22.5% | +4.0% | +90.0% | -4.9% | +40.4% | -10.6% | -22.0% | +19.6% | +23.6% | |
| – | – | -5.2% | -88.0% | +172.6% | -857.3% | – | -93.3% | – | – | – | |
| – | – | – | -154.6% | – | – | -151.5% | – | – | – | -33.6% | |
| – | +10.2% | -10.6% | +36.4% | +46.8% | +57.5% | -36.6% | -6.6% | -16.3% | -4.5% | +87.8% | |
| – | -96.4% | +429.7% | -86.8% | +84.9% | +1,935.4% | -88.9% | -66.2% | -5.6% | – | -124.1% | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | -1.0% | -104.9% | – | -93.6% | -314.9% | -85.1% | +1,815.6% | -61.8% | |
| – | -102.8% | – | -104.2% | +765.9% | – | -95.8% | -361.4% | -84.9% | +1,697.6% | -81.6% | |
| – | -158.6% | – | +448.1% | -193.9% | – | -17.7% | -322.0% | – | +1,557.1% | -33.6% | |
| – | – | +64.9% | +369.1% | -92.4% | -1,418.0% | – | -6.3% | -56.3% | +236.8% | -27.9% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.